CCCC Competitors & Alternatives
Compare C4 Therapeutics Inc with similar stocks in the same industry
Biotechnology
CCCC
Main Stock$3.92
Tradestie Score
53
Market Cap
$153.02M
Revenue Growth
-0.2%
Analyst Upside
+240.1%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.21
|
$468.01M | - | 54 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$21.98
|
$463.20M | - | 59 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$9.72
|
$457.09M | - | 60 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.36
|
$454.29M | - | 58 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$20.41
|
$448.32M | - | 60 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$28.10
|
$422.50M | - | 61 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$75.93
|
$410.79M | - | 57 | Compare |
More CCCC Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry